Defender Capital, LLC. - Q1 2021 holdings

$280 Million is the total value of Defender Capital, LLC.'s 38 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 50.0% .

 Value Shares↓ Weighting
VGSH BuyVANGUARD SHORT TERM TREASURYetf$47,935,000
+18.6%
779,171
+18.8%
17.10%
-2.8%
DHR BuyDANAHER CORP$35,349,000
+35.7%
156,433
+33.4%
12.61%
+11.2%
BRKB BuyBERKSHIRE HATHAWAY CLASS$33,014,000
+13.5%
128,947
+2.8%
11.78%
-7.0%
FTV BuyFORTIVE CORPORATION$20,769,000
+35.5%
293,664
+35.7%
7.41%
+11.0%
COST BuyCOSTCO WHOLESALE CO$17,029,000
+70.4%
48,145
+81.5%
6.07%
+39.7%
AXON BuyAXON ENTERPRISE INC$12,555,000
+65.3%
87,630
+41.3%
4.48%
+35.4%
LCTX BuyLINEAGE CELL THERAPEUTIC$11,618,000
+39.4%
4,950,720
+4.5%
4.14%
+14.2%
NUAN BuyNUANCE COMMUN INC$7,853,000
+137.8%
173,508
+131.6%
2.80%
+94.8%
CFX BuyCOLFAX CORPORATION$6,081,000
+36.0%
138,791
+18.7%
2.17%
+11.5%
TDY BuyTELEDYNE TECHNOLOGIE$4,382,000
+20.4%
10,565
+13.8%
1.56%
-1.3%
OCX NewONCOCYTE CORP$3,122,000604,450
+100.0%
1.11%
RUN NewSUNRUN$2,453,0005,000
+100.0%
0.88%
AMWL BuyAMERICAN WELL CORP$2,346,000
-1.3%
134,825
+43.7%
0.84%
-19.1%
PTN NewPALANTIR TECHNOLOGIES$2,316,00010,000
+100.0%
0.83%
CGEN BuyCOMPUGEN LIMITEDord$2,014,000
-18.8%
233,872
+14.2%
0.72%
-33.5%
INO BuyINOVIO PHARMA$1,210,000
+37.3%
130,466
+31.1%
0.43%
+12.8%
ITEQ BuyBLUESTAR ISRAEL TECHNOLOGYetf$717,000
-4.7%
11,037
+0.9%
0.26%
-21.7%
ANIP BuyANI PHARMACEUTICALS$687,000
+57.6%
19,000
+26.7%
0.24%
+28.9%
IVV BuyIVVetf$468,000
+6.1%
1,176
+0.2%
0.17%
-13.0%
DIS BuyWALT DISNEY CO$388,000
+5.4%
2,105
+3.7%
0.14%
-13.8%
VSAT NewVIASAT INC$288,0006,000
+100.0%
0.10%
ITMR NewITAMAR MEDICAL$287,00012,000
+100.0%
0.10%
ARWR NewARROWHEAD PHARMACUTICLES$270,0004,000
+100.0%
0.10%
KMI NewKINDER MORGAN INC$250,00015,000
+100.0%
0.09%
CSCO NewCISCO SYSTEMS INC$208,0004,016
+100.0%
0.07%
STCN BuySTEEL CONNECT INC$113,000
+769.2%
57,000
+235.3%
0.04%
+566.7%
ATNX NewATHENEX INC$86,00020,000
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-04-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL CL B20Q3 202324.4%
DANAHER CORPORATION COM20Q3 202318.3%
STAAR SURGICAL CORPORATION20Q3 202320.2%
FORTIVE CORPORATION20Q3 202314.3%
MONSTER BEVERAGE CORPORATION20Q3 202317.3%
APPLE INC20Q3 20230.6%
AMAZON INC COM20Q3 20230.4%
VANGUARD SHORT TERM TREASURY ETF IV17Q3 202323.9%
LINEAGE CELL THERAPEUTICS INC17Q3 20234.8%
COMPUGEN LTD ORD17Q1 20231.9%

View Defender Capital, LLC.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-01-23
13F-HR2023-10-23
13F-HR2023-07-18
13F-HR/A2023-05-16
13F-HR2023-04-27
13F-HR2023-01-12
13F-HR2022-10-18
13F-HR2022-07-26
13F-HR/A2022-06-07

View Defender Capital, LLC.'s complete filings history.

Compare quarters

Export Defender Capital, LLC.'s holdings